Profile picture

Doctor Prathap Kanagala

Liverpool University Hospitals NHS Trust, Liverpool (United Kingdom of Great Britain & Northern Ireland)
Membership: FESC Member HFA Member
Follow
Biography
Dr Kanagala (MBBS, MRCP, PhD, FESC, FHFA) is a Honorary Clinical Associate Professor (University of Liverpool) and Consultant Cardiologist at Liverpool University Hospitals NHS Trust. His primary interests are in heart failure and cardiac imaging. He obtained his PhD from the University of Leicester for his work related to characterising HFpEF with cardiac MRI. His awards to date include: University PhD prize; Young Investigator Award (Runner-up) at the British Society for Heart Failure (2015) and Early Career Award (Clinical) Finalist at the Society for Cardiovascular Magnetic Resonance (2018). He has previously held positions in both the Communications and Education Committees of the British Society of Echocardiography delivering multiple National Guideline protocols as either lead or co-author and has published extensively in the fields of heart failure, cardiac MRI and biomarkers. He is currently involved in numerous multi-centre trials, primarily as Principal Investigator.
Logo ESC

Contributor content

Microvascular dysfunction in heart failure with preserved ejection fraction: prevalence and prognostic implications
Presentation
Microvascular dysfunction in heart failure with preserved ejection fraction: prevalence and prognostic implications
Prevalence of microvascular dysfunction and association with clinical outcomes in heart failure with preserved ejection fraction
Presentation
Prevalence of microvascular dysfunction and association with clinical outcomes in heart failure with preserved ejection fraction
Plasma Tenascin-C: a novel prognostic biomarker in heart failure with preserved ejection fraction
Presentation
Plasma Tenascin-C: a novel prognostic biomarker in heart failure with preserved ejection fraction
Characterizing heart failure with preserved and reduced ejection fraction: an integrated clinical, imaging and plasma biomarker approach
Presentation
Characterizing heart failure with preserved and reduced ejection fraction: an integrated clinical, imaging and plasma biomarker approach
Relation of focal and diffuse fibrosis assessed by cardiovascular magnetic resonance imaging to clinical outcome in heart failure with preserved ejection fraction
Presentation
Relation of focal and diffuse fibrosis assessed by cardiovascular magnetic resonance imaging to clinical outcome in heart failure with preserved ejection fraction
Prevalence and prognostic significance of right ventricular dysfunction in heart failure with preserved ejection fraction
Presentation
Prevalence and prognostic significance of right ventricular dysfunction in heart failure with preserved ejection fraction
Left atrial ejection fraction: a novel diagnostic and prognostic biomarker in heart failure with preserved ejection fraction, irrespective of cardiac rhythm
Presentation
Left atrial ejection fraction: a novel diagnostic and prognostic biomarker in heart failure with preserved ejection fraction, irrespective of cardiac rhythm
Utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction for diagnostic and prognostic evaluation
Presentation
Utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction for diagnostic and prognostic evaluation

ESC 365 is supported by